AM Best Ratings Affirmation: AM Best has affirmed the Financial Strength Rating (FSR) of A+ for Allstate Insurance Group and various other subsidiaries, indicating strong financial stability and performance.
Economic Challenges Impacting Performance: Allstate faced economic challenges and increased pressures from catastrophic events in 2022 and 2023, leading to a comprehensive profit improvement plan that has begun to show results in 2024.
Balance Sheet Strength and Capitalization: Allstate's risk-adjusted capitalization improved significantly in 2024, supported by a robust reinsurance program and access to capital markets, although it remains below historical levels.
Outlook Changes for Other Groups: The outlooks for Allstate New Jersey are negative due to recent operating results, while Castle Key Group's outlook was revised to positive, reflecting improvements in their operating performance metrics.
ALL
$211.94+Infinity%1D
Analyst Views on ALL
Wall Street analysts forecast ALL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ALL is 241.50 USD with a low forecast of 201.00 USD and a high forecast of 300.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
17 Analyst Rating
Wall Street analysts forecast ALL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ALL is 241.50 USD with a low forecast of 201.00 USD and a high forecast of 300.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
13 Buy
3 Hold
1 Sell
Moderate Buy
Current: 207.180
Low
201.00
Averages
241.50
High
300.00
Current: 207.180
Low
201.00
Averages
241.50
High
300.00
Morgan Stanley
Bob Huang
Overweight -> Equal Weight
downgrade
$245 -> $215
2025-12-16
New
Reason
Morgan Stanley
Bob Huang
Price Target
$245 -> $215
2025-12-16
New
downgrade
Overweight -> Equal Weight
Reason
Morgan Stanley analyst Bob Huang downgraded Allstate to Equal Weight from Overweight with a price target of $215, down from $245. While Allstate has made significant effort to return to strong profitability and improving growth, the firm believes the thesis is "now largely understood by investors," the analyst says. In personal lines, carriers that spent the past two years repairing margins will increasingly shift from defense to offense, adds the analyst, who contends that the "path for a more challenging year is relatively clear."
Mizuho
Yaron Kinar
Outperform
initiated
$254
2025-12-15
New
Reason
Mizuho
Yaron Kinar
Price Target
$254
2025-12-15
New
initiated
Outperform
Reason
Mizuho analyst Yaron Kinar initiated coverage of Allstate with an Outperform rating and $254 price target. The firm rolled out coverage of 23 companies, including six life insurers, 11 property and casualty insurers and six insurance brokers. It prefers life insurance, saying the group is undervalued despite credit concerns. Mizuho is less constructive on the property and casualty insurers and brokers citing market softening, plateauing investment yields and reserve concerns. The analyst expects insurance broker organic growth to moderate and is concerned that this may drive more aggressive acquisitions.
Roth Capital
Harry Fong
Buy
maintain
$230 -> $240
2025-11-26
Reason
Roth Capital
Harry Fong
Price Target
$230 -> $240
2025-11-26
maintain
Buy
Reason
Roth Capital analyst Harry Fong raised the firm's price target on Allstate to $240 from $230 and keeps a Buy rating on the shares. The company's "significant earnings beat" was chiefly due to much better underlying results and favorable loss reserve development in personal auto injury and physical damage coverages, while its personal auto policies-in-force increased 1.3%, which was previously disclosed, the analyst tells investors in a research note.
HSBC
Vikram Gandhi
Hold -> Buy
upgrade
$267 -> $259
2025-11-17
Reason
HSBC
Vikram Gandhi
Price Target
$267 -> $259
2025-11-17
upgrade
Hold -> Buy
Reason
HSBC analyst Vikram Gandhi upgraded Progressive (PGR) to Buy from Hold with a price target of $259, down from $267. Progressive shares have underperformed closest peer Allstate (ALL) by about 26% and the S&P 500 by about 36% since mid-April, notes the analyst, who attributes this to a combination of headwinds faced by its personal auto business given slowing policy-in-force growth driven by intense competition, increasingly fading pricing momentum and falling interest rates. However, while the firm thinks the underperformance was "justified to some extent," it sees this presenting an opportunity as the firm notes that management emphasized on the Q3 call that it remains focused on growth, but not at the cost of profitability and the firm views regulatory moves to unlock excess capital and share buybacks being added to the capital returns mix as positives.
About ALL
The Allstate Corporation protects people from life’s uncertainties with a wide array of protection for autos, homes, electronic devices and identity theft. The Company’s products are available through Allstate agents, independent agents, major retailers, online and at the workplace. Its Allstate Protection segment offers private passenger auto, homeowners, other personal lines and commercial insurance. Its Run-off Property-Liability segment includes property and casualty insurance coverage. The Company’s Protection Services segment provides consumer product protection plans, device and mobile data collection services and analytic solutions using automotive telematics information, roadside assistance, protection and insurance products and identity protection and restoration through Allstate Protection Plans, Allstate Dealer Services, Allstate Roadside, Arity and Allstate Identity Protection.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
